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E-mail: pierre-edouard.fournier@univ-amu.frIntroductionThe genus Listeria is composed of 17 species, including two that
are recognized pathogens. Of these, L. monocytogenes is consid-
ered as the only human pathogen causing listeriosis, a highly lethal
opportunistic infection caused by ingestion of contaminated food
[1]. The second pathogenic species is L. ivanovii, which mostly
responsible for abortions, stillbirths and neonatal septicaemias in
sheep and cattle [1]. However, rare cases of human infection by
this species have been published. To date, eight human L. ivanovii
infections have been reported, including four cases of bacter-
aemia and one case each of mesenteric adenitis, uterine discharge
and stillbirth (Table 1). The eighth case was not detailed [3].
Here we report a rare case of L. ivanovii vascular infection in
a 78-year-old man. We applied real-time genomics to compare
the genetic content of this strain to those of other L. ivanovii
strains available in public databases.New Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artiPatient and MethodsOn 29 November 2014 a 78-year-old man was hospitalized in
Timone Hospital, Marseille, France, for suspected infectious
endocarditis. The patient had had a mechanical Bentall prosthesis
inserted in 2010 as well as a mitral valve regurgitation repaired in
1998. He also had a dissection of the descending thoracic aorta.
Over the past 10 days the patient had developed fatigue, fever,
chills and concomitant back pain. Transesophageal echocardiog-
raphy revealed moderate leakages of the mitral and mechanical
aortic valves but no vegetation. However, because endocarditis
was suspected, empirical intravenous amoxicillin (12 g/d) and
gentamicin (3 mg/kg/d) was initiated after blood was collected for
culture. On 4 December, as a result of a persistent inﬂammatory
syndrome (C-reactive protein level 264 mg/L), a new aortic
paraprosthetic leakage was detected by transesophageal echo-
cardiography. A thoracic computed tomographic scan revealed
increased size of the previously known descending aorta
dissection. Blood cultures and systematic serology assays
(Aspergillus sp., Bartonella sp., Brucella sp., Legionella pneumophila,
Mycoplasma pneumoniae, Q fever) were negative. Antibiotics
were changed to intravenous imipenem (3 g/d) and vancomycin
(2 g/d). On 24 December liposomal amphotericin B (3 mg/kg/d)
was added to treat a persistent biological inﬂammatoryNew Microbe and New Infect 2016; 10: 87–92
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TABLE 1. Studies reporting human cases of Listeria ivanovii infections [2]
Clinical condition Sex Age (years) Underlying condition Year reported Study
Unknown Unknown 79 Unknown 1971 [3]
Uterine discharge F Unknown Pregnancy 1985 [4]
Mesenteric adenitis Unknown Unknown Unknown 1985 [4]
Stillbirth F Unknown Pregnancy 1990 [5]
Bacteraemia M 26 AIDS, lymphoma 1994 [6]
Bacteraemia M 39 Substance abuse 1994 [7]
Bacteraemia M 64 Hepatic carcinoma 2006 [29]
Gastroenteritis, Bacteraemia M 55 Immunosuppression 2007 [2]
Aortic prosthesis infection M 78 Immunosuppression 2015 This study
88 New Microbes and New Infections, Volume 10 Number C, March 2016 NMNIsyndrome. On 30 December the patient underwent a right
posterolateral thoracotomy for resection of a mediastinal ab-
scess. Culture of peroperative specimens were positive for a
Listeria isolate that was identiﬁed as L. ivanovii using 16S rRNA
sequencing (99.9% identity with GenBank accession no.
CP009577). The antibiotic therapy was changed again to intra-
venous amoxicillin (12 g/d) and gentamicin (3 mg/kg/d). How-
ever, on 8 January 2015 the patient developed respiratory
distress and was transferred to the intensive care unit, where
atrial ﬁbrillation and pleural effusion were diagnosed. On 14
January the patient underwent pleural drainage, right axillofe-
moral bypass, reimplantation of the subclavian artery on the
common carotid artery, removal of the thoracic endoprosthesis
and closure of the aortic stump. However, his condition dete-
riorated, and the patient died on 23 January.
Genome sequencing
Listeria ivanovii strain G770 was deposited in the CSUR collec-
tion (WDCM 875) under reference P1995. Genomic DNA of
Listeria ivanovii was extracted using an EZ-One automate
(Qiagen, Hilden, Germany). Genomic DNA was quantiﬁed by a
Qubit assay with the high sensitivity kit (Life Technologies,
Carlsbad, CA, USA) to 10.8 ng/μL. Genomic sequencing was
performed using the paired-end strategy. Genomic DNA (1 ng)
was used to prepare the paired-end library with the Nextera
XT DNA sample prep kit (Illumina, San Diego, CA, USA). TheFIG. 1. Phylogenetic analysis of Listeria ivanovii strains based on comparison
joining method and Kimura two-parameter model. Genome sequence acces
results of bootstrap resampling (n = 1000). Listeria monocytogenes was used a
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licetagmentation step fragmented and tagged the DNA. Then
limited-cycle PCR ampliﬁcation (12 cycles) completed the tag
adapters and introduced dual-index barcodes. After puriﬁcation
on AMPure XP beads (Beckman Coulter, Fullerton, CA, USA),
the library was sequenced on the MiSeq sequencer (Illumina) in
a single 39-hour run in 2 × 250 bp. A total of 455 380 paired-
end reads was obtained for this project, with a 871K/mm2
cluster density with a cluster passing quality control ﬁlters of
80.5%. The reads were trimmed and ﬁltered according to the
read qualities.
Bioinformatic analysis
The reads obtained after sequencing were assembled using the
A5 assembler [9]. Then a ﬁnishing step was performed with
the Mauve aligner software and CLC bioserver [10]. After
assembly and ﬁnishing, the size of the genome was 2.9 Mb.
Open reading frames (ORFs) were predicted by Prodigal
software (http://prodigal.ornl.gov/) with default parameters.
Functional annotation was done by comparison of ORF se-
quences to the GenBank [11] and Clusters of Orthologous
Groups (COGs) database using BLASTP. tRNAs and rRNAs
were detected using tRNAscan-SE v.1.21 [12] and RNAmmer
1.2 [13], respectively.
The absence of plasmids was veriﬁed both by searching the
gene annotation for any plasmid-related gene and by mapping all
contigs against previously published Listeria plasmid sequences.of sequences from hlyA gene using MEGA 6 software with neighbour-
sion numbers are indicated in parentheses. Numbers at nodes indicate
s outgroup. Scale bar = 2% nucleotide differences.
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performed a phylogenetic analysis (Fig. 1) by comparing the
sequences of the hlyA gene [14] using the neighbour-joining
method and MEGA 6 software [15]. Subsequently we
compared the genomic content of strain G770 and those of the
most closely related L. ivanovii strains available in GenBank. The
genome sequence similarity between studied strains was eval-
uated with GGDC software (http://ggdc.dsmz.de).
The analysis of virulence factors was performed by searching
the genes already identiﬁed as responsible for virulence in
L. ivanovii (six genes of the LIPI-1 cluster, internalin genes, genes
of stress survival islet 1 (SS1)) and by screening every gene that
was speciﬁc to strain G770 for a putative role in virulence. The
CRISPRFinder algorithm was used to identify putative CRISPR
(clustered regularly interspaced short palindromic repeat) loci
[16].
Nucleotide sequence accession number
The genome sequence from L. ivanovii strain G770 was
deposited in GenBank under accession number CVPH01
000001–CVPH01000017.ResultsThe draft genome sequence of L. ivanovii strain G770 consisted
of 17 scaffolds after assembly and ﬁnishing. No plasmid was
detected. The chromosome size, G+C content and number of
genes were 2 965 602 bases, 37.10% and 2946 genes, respec-
tively. Among these genes, 2850 were protein-coding genes and
96 were RNAs (21 rRNAs, 74 tRNAs, one tmRNA). A total of
2433 genes were assigned to COGs (82, 25%). Of these, 2393
genes were assigned a putative function (81.2%), and 553
(18.8%) were annotated as hypothetical proteins.
Phylogenetically, two lineages were identiﬁed among
L. ivanovii strains, including one that was made of L. ivanovii
subsp. ivanovii strains, including strain G770, and a second made
of L. ivanovii subsp. londoniensis strains (Fig. 1). The percentages
of nucleotide sequence similarity between strain G770 and
L. ivanovii strains for the hlyA gene ranged from 94.35% with the
two strains of subspecies londoniensis to 99.87% with the other
three strains of subspecies ivanovii. For 16S rRNA, theTABLE 2. Differential gene content among Listeria ivanovii strains s
Compared strains
L. ivanovii subsp.
ivanovii PAM 55
L. ivanovii subsp. ivanovii
strain WSLC 3010
L. ivanovii su
strain WSLC
No. of additional genes
in strain G770
42 53 50
No. of missing genes in
strain G770
12 11 13
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This is an open access artipercentages of nucleotide similarity were 99.87 and 100% be-
tween strain G770 and the strains of the subspecies londoniensis
and ivanovii, respectively. The G770 strain exhibited GGDC
values of 99.3% with other L. ivanovii subsp. ivanovii strains and
51.2 to 51.7% with L. ivanovii subsp. londoniensis strains
(Supplementary Table S1).
As detailed in Table 2, strain G770 exhibited much less
differences with strains from L. ivanovii subsp. ivanovii than
with those from subsp. londoniensis. Of the G770-speciﬁc
genes, 21 were absent from all other compared genomes
L. ivanovii strains (Table 3). In addition, strain G770 had 12, 11
and 13 missing genes with regard to subspecies londoniensis
(Table 2). Supplementary Table S2 lists the missing in strain
G770.
Among the 21 strain G770–speciﬁc genes, ﬁve encoded
proteins similar to type I restriction-modiﬁcation genes of
L. monocytogenes and one was mostly similar to vanZ, a
component of the vancomycin-resistant operon in Staphylo-
coccus pseudintermedius (Table 3). Strain G770 also had ﬁve
speciﬁc genes encoding metabolic enzymes such as helicases,
transferases and acetyl–coenzyme A synthase. Finally, the strain
exhibited six genes encoding hypothetical proteins and one
encoding a membrane protein (Table 3).
As other L. ivanovii strains, strain G770 had a complete LIPI-1
virulence cluster. However, although the sequences from the
ﬁve LIPI-1 genes prfA, LLO, mpl, plcC and plcB of all compared
genomes were identical, strain G770 differed from other strains
in the actA gene sequence (Supplementary Table S3). Never-
theless, the annotated domains of the ActA protein were
similar to those of ActA proteins from other strains of the
subspecies ivanovii (Supplementary Fig. S1).
Strain G770, like all other compared L. ivanovii strains,
exhibited 16 internalin or internalin-like genes including inlA,
inlB and inlC (Supplementary Table S4). In addition, we identi-
ﬁed in strain G770 ﬁve genes related to the SSI-1
(Supplementary Table S5). These genes were also present in
all compared L. ivanovii genomes.
The genome of strain G770 harboured one CRISPR region
(Supplementary Fig. S2), whereas the other three subspecies
ivanovii strains exhibited three CRISPR regions each and the
subspecies londoniensis strains WSLC30151 and WSLC30167
had two and three CRISPRs, respectively [17].tudied
bsp. ivanovii
3009
L. ivanovii subsp. londoniensis
strain WSLC 30151
L. ivanovii subsp. londoniensis
strain WSLC 30167
438 450
513 447
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TABLE 3. List of genes present in strain G770 but absent or differentially present in other Listeria ivanovii subsp. ivanovii strains
Locus
(CVPH01000001–CVPH01000017) Putative function (COGs category) Best match with:
Presence in other L. ivanovii
subsp. ivanovii strains
PAM
55
WSLC
3009
WSLC
3010
Scaffold1.1_160a Membrane protein (not in COGs) Lactobacillus paracasei − − −
Scaffold1.1_161a S-transferase (not in COGs) Vibrio tubiashii − − −
Scaffold1.1_162a,c Type I restriction-modiﬁcation protein subunit M (V) Listeria monocytogenes − − −
Scaffold1.1_163a,c Type I restriction-modiﬁcation protein subunit S (V) L. monocytogenes − − −
Scaffold1.1_164a,c Type I deoxyribonuclease HsdR (V) L. monocytogenes − − −
Scaffold1.1_165a,c Type I RM HsdR (V) L. monocytogenes − − −
Scaffold1.1_166a,c Type I mrr restriction system protein (V) L. monocytogenes − − −
Scaffold1.1_167a DNA helicase (L) L. monocytogenes − − −
Scaffold1.1_168a DNA helicase related protein (L) Listeria marthii − − −
Scaffold1.1_169a Antibiotic resistance protein VanZ (not in COGs) Staphylococcus
pseudintermedius
− − −
Scaffold1.1_170a Hypothetical protein (L) Listeria seeligeri − − −
Scaffold1.1_171b Putative secreted, lysin rich protein (not in COGs) Listeria ivanovii − − −
Scaffold1.1_172 Threonine aldoase(E) Listeria seeligri − − −
Scaffold1.1_173a Hypothetical protein (S) L. monocytogenes − − −
Scaffold1.1_174a PF07510 family protein (S) Staphylococcus hominis − − −
Scaffold1.1_175a Hypothetical protein Not in COGs) L. monocytogenes − − −
Scaffold1.1_176a DNA-cytosine methyltransferase (L) Enterococcus faecalis − − −
Scaffold1.1_177a Hypothetical protein (L) E. faecalis − − −
Scaffold1.1_178a DNA mismatch repair protein (Not in COGs) Butyrivibrio sp. FCS014 − − −
Scaffold1.1_179 PTS cellbiose transporter subunit (S) Listeria innocua − − −
Scaffold1.1_180 Transcriptional regulator (K) L. ivanovii − − −
Scaffold1.1_181 Hydroxyethylthiazote kinase (H) L. ivanovii − − −
Scaffold1.1_182 Phosphome thylpyrimidine kinase (H) L. ivanovii − − −
Scaffold1.1_183 Thiamine-phosphate pyrophosphorylase (H) L. ivanovii − − −
Scaffold1.1_184 6-Phospho-beta-glucosidase (G) L. ivanovii − − −
Scaffold1.1_185 Membrane protein, putative (not in COGs) L. ivanovii − − −
Scaffold1.1_186a F-box/FBD/LRR-repeat protein (S) L. monocytogenes − − −
Scaffold1.1_187a F-box/FBD/LRR-repeat protein (S) L. monocytogenes − − −
Scaffold1.1_188a Acetyl-coenzyme A synthetase (S) L. monocytogenes − − −
Scaffold1.1_189b Transcription antiterminator LicT (K) L. seeligri − − −
Scaffold1.1_190b PTS-beta-glucosidase (G) L. ivanovii − − −
Scaffold1.1_191b 6-Phospho-beta-glucosidase (G) L. seeligri − − −
Scaffold1.1_192b Wall-associated RHS family protein (M) L. ivanovii − − −
Scaffold1.1_193b Heat repeat-containing pbs lyase (C) L. ivanovii − − −
Scaffold1.1_194b Hypothetical protein (not in COGs) L. ivanovii − − −
Scaffold1.1_195b Hypothetical protein (not in COGs) L. ivanovii − − −
Scaffold1.1_233b Hypothetical protein (not in COGs) L. ivanovii − − −
Scaffold1.1_303b Antibiotic resistance protein VanZ (V) L. monocytogenes − − −
Scaffold1.1_347 Multidrug ABC transporter ATP-binding protein (V) L. ivanovii + − −
Scaffold1.1_348 CRISPR-associated protein Cas6 (L) L. ivanovii + − −
Scaffold1.1_349 CRISPR-associated protein Cst1 (not in COGs) L. ivanovii + − −
Scaffold1.1_350 CRISPR-associated protein (L) L. ivanovii + − −
Scaffold1.1_351 CRISPR-associated protein Cas5 (L) L. ivanovii + − −
Scaffold1.1_352 CRISPR-associated protein Cas3 (R) L. ivanovii + − −
Scaffold1.1_354 CRISPR-associated protein Cas4 (L) L. monocytogenes + − −
Scaffold1.1_355 CRISPR-associated exonuclease Cas1 (L) L. ivanovii + − −
Scaffold1.1_356 CRISPR-associated protein Cas2 (L) L. ivanovii + − −
Scaffold1.1_529 4-Dihydroxy-2-naphthoate octaprenyltransferase (not in
COGs)
L. ivanovii + − −
Scaffold1.1_918 Molybdenum cofactor biosynthesis protein D (H) L. ivanovii − + +
Scaffold1.1_1236 Conserved hypothetical protein (not in COGs) L. ivanovii + − −
Scaffold1.1_2852b Hypothetical protein (not in COGs) L. monocytogenes − − −
Scaffold1.1_2853a Conserved hypothetical protein (not in COGs) L. monocytogenes − − −
Scaffold1.1_2855b Hypothetical protein (not in COGs) L. monocytogenes − − −
COGs, Clusters of Orthologous Groups database.
aGenes present only in strain G770.
bGenes present in L. ivanovii subsp. londoniensis strains.
cGenes associated to type I restriction-modiﬁcation system.
90 New Microbes and New Infections, Volume 10 Number C, March 2016 NMNIDiscussionTo date, only eight cases of human infections caused by
L. ivanovii have been reported in the literature. Of these, two
were diagnosed in patients over 60 years, and most occurred in
immunocompromised patients (two pregnant women, and one
case each of AIDS, drug abuse, hepatic lymphoma and immu-
nosuppression; Table 1). In the remaining two cases of human
L. ivanovii infection, no underlying condition was describedNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice(Table 1). To our knowledge, we herein present the ﬁrst case of
L. ivanovii vascular infection. In an effort to determine whether
this unusual presentation was due to an increased virulence of
strain G770, we compared the genome of strain G770 to those
of other L. ivanovii strains.
In Listeria species, the LIPI-1 cluster is the major pathogenesis
factor. All Listeria species lacking this gene cluster are not
pathogenic [18]. In L. ivanovii, the LIPI-1 cluster is made of six
genes, including a pore-forming toxin (listeriolysin O) and two
phospholipases (plcC and plcB) which cooperate to lyse theEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 10, 87–92
nses/by-nc-nd/4.0/)
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surface protein (ActA) that is responsible for intracellular
bacterial motility and spread; a metalloprotease (mpl) that is
involved in the maturation of proPlcB; and a transcriptional
activator (PrfA) that controls the expression of LIPI-1 genes
[19]. Studies have shown that mutations in the prfA gene inhibit
bacterial cell-to-cell spread and reduce bacterial virulence in
L. monocytogenes [20]. Mutations in different parts of ActA,
notably the N-terminal region, cause several unusual motility
and actin polymerization phenotypes in L. monocytogenes [21].
Strain G770 possessed all six genes of the LIPI-1 cluster but
varied in hly and actA when compared to other strains from
L. ivanovii subsp. ivanovii (Supplementary Table S3). The differ-
ences in ActA domains are displayed in Supplementary Fig. S1.
However, the ActA domains involved in virulence are
conserved in all strains [21]. Therefore, the observed differ-
ences in cluster LIPI-1 or ActA do not support an increased
virulence of strain G770.
Among other known virulence factors of Listeria species,
internalins such inlA, inlB and inlC are essential for host inva-
sion and cell-to-cell spread [22]. However, strain G770 did not
exhibit differences in internalin content (Supplementary
Table S4) compared to other L. ivanovii strains. In addition,
strain G770 also possessed the stress survival islet 1
(Supplementary Table S5), known in L. monocytogenes to be
linked to tolerance towards acidic, salt, bile and gastric stress
[23]. Again, we found no difference in SSI-1 content among
studied strains. Finally, we detected CRISPRs in strain G770
(Supplementary Fig. S2). The presence of CRISPR regions
confers to Listeria species an adaptive immunity that protects
them against invading bacteriophages and plasmids [24]. How-
ever, no relationship between the number of CRISPRs and
virulence has been reported for these bacteria.
In addition, strain G770 exhibited 21 speciﬁc genes (Table 3).
The best matches for 12 of these genes were found in both
Listeria seeligeri and L. monocytogenes. Only one speciﬁc gene
(Scaffold1.1_178) was not found in the genus Listeria, thus
conﬁrming the highly conserved nature of genomes in this
genus [22]. Of these additional genes, six may have roles in
virulence or resistance of strain G770, including ﬁve genes
similar to a type I restriction-modiﬁcation system of Listeria
monocytogenes. This is the ﬁrst time that a type I restriction-
modiﬁcation system is found in L. ivanovii. Restriction-
modiﬁcation systems effectively allow discrimination of self
and nonself in bacteria [25]. These systems protect against
phages, plasmids and transposons [25]. In addition, type I
restriction-modiﬁcation systems play roles in various cellular
processes including host defence and virulence, and they even
control the speed of evolution of the organism [25]. One study
showed that bacteria that have acquired a competentNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access artirestriction-modiﬁcation system acquire new properties espe-
cially during colonization of new habitats [8]. Therefore, we
assume that the type I restriction-modiﬁcation system identiﬁed
in strain G770 may have conferred to it an increased virulence.
Strain G770 also exhibited a vanZ gene. VanZ is an accessory
protein that is part of the Tn1546 transposon [26]. The pres-
ence of this transposon confers resistance to glycopeptides in
Enterococcus faecium [26]. In the absence of the other compo-
nents of the Tn1546 transposon, VanZ confers low-level
resistance to teicoplanin (not to vancomycin) [27]. However,
no case of resistance to vancomycin has been reported for
strains of Listeria spp. originating from humans, food or the
environment, and strain G770 was not resistant to glycopep-
tides [28].
Overall, the genomic analysis of L. ivanovii subsp. ivanovii
strain G770, which caused a deadly aortic infection, enabled
identiﬁcation of speciﬁc characteristics among other L. ivanovii
strains, including a type I restriction-modiﬁcation system that
may have conferred to it an increased virulence.AcknowledgementsThis study was funded by the Fondation Méditerranée Infection.Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
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